Kala Pharmaceuticals, Inc. Business Finance Contracts & Agreements
27 Contracts & Agreements
- Loan Agreements (7 contracts)
- Purchase Agreements (5)
- Registration Rights Agreements (4)
- Stock Agreements (8)
- Underwriting Agreements (3)
- Registration Rights Agreement, dated June 26, 2024, by and among KALA BIO, Inc. and the parties thereto (Filed With SEC on June 27, 2024)
- Securities Purchase Agreement, dated June 26, 2024, by and among KALA BIO, Inc. and the purchasers party thereto (Filed With SEC on June 27, 2024)
- Securities Purchase Agreement, dated March 25, 2024, by and among KALA BIO, Inc. and the purchasers party thereto (Filed With SEC on March 26, 2024)
- Securities Purchase Agreement, dated December 21, 2023, by and among KALA BIO, Inc. and the purchasers party thereto (Filed With SEC on December 22, 2023)
- Fifth Amendment to Loan and Security Agreement, dated August 2, 2023, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on August 4, 2023)
- Fourth Amendment to Loan and Security Agreement, dated August 1, 2023, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on August 4, 2023)
- Form of Inducement Restricted Stock Unit Agreement (Filed With SEC on August 4, 2023)
- Registration Rights Agreement, dated March 2, 2023, by and among the Registrant and the persons party thereto (Filed With SEC on March 3, 2023)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on March 3, 2023)
- Third Amendment to Loan and Security Agreement, dated December 27, 2022, by and among Kala Pharmaceuticals, Inc., Combangio, Inc. and Oxford Finance LLC, as collateral agent and... (Filed With SEC on December 27, 2022)
- Securities Purchase Agreement, dated November 28, 2022, by and among Kala Pharmaceuticals, Inc. and the purchasers party thereto (Filed With SEC on November 28, 2022)
- Form of Series E Preferred Stock Certificate (Filed With SEC on November 28, 2022)
- Second Amendment to Loan and Security Agreement, dated May 21, 2022, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on August 11, 2022)
- First Amendment to Loan and Security Agreement, dated November 15, 2021, by and among the Registrant, Combangio, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on August 11, 2022)
- Asset Purchase Agreement, by and between Kala Pharmaceuticals, Inc., Alcon Pharmaceuticals Ltd. and Alcon Vision, LLC (Filed With SEC on May 23, 2022)
- Loan and Security Agreement, dated May 4, 2021, by and among Kala Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on May 5, 2021)
- Third Amended and Restated Registration Rights Agreement of the Registrant dated April 4, 2016, as amended by Amendment No. 1 dated December 13, 2017, of the Registrant (Filed With SEC on February 25, 2021)
- Underwriting Agreement, dated March 10, 2020, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of... (Filed With SEC on March 12, 2020)
- Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on May 9, 2019)
- Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on March 12, 2019)
- Form of Inducement Grant Stock Option Agreement (Filed With SEC on November 8, 2018)
- Underwriting Agreement, dated October 2, 2018, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and... (Filed With SEC on October 5, 2018)
- Form of Inducement Grant Stock Option Agreement (Filed With SEC on August 9, 2018)
- Loan and Security Agreement, dated November 20, 2014, by and between the Registrant and Square 1 Bank, as amended (Filed With SEC on April 2, 2018)
- KALA PHARMACEUTICALS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 10, 2017)
- KALA PHARMACEUTICALS, INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on July 10, 2017)
- KALA PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT April 6, 2016 (Filed With SEC on June 23, 2017)
